Low bids for Pfizer building signal weak market: experts

New York /
Jun.June 28, 2010 11:00 AM

The relatively low bidding offers coming in for the Pfizer building
at 685 Third Avenue reflect the weakness of the market, experts told
Crain’s. More than a dozen firms — which are rumored to include SL
Green Realty, Vornado Realty Trust and George Comfort & Sons — made
offers last week on the 650,000-square-foot property near Grand
Central. Several bids came in at around $150 million, or $230 a
square foot, compared to other recent sales of major office buildings, which have gone
for an average of $635 a square foot. Since the Pfizer property, between 43rd and 44th streets, will be empty, the buyer will need to spend

millions of dollars on marketing, leasing commissions and tenant
improvements according to Crain’s. Although leasing activity began picking up at the end of

2009, it’s still far below the higher levels of 2006 and 2007, and
experts are also still worried about the strength of the economic
recovery. CB Richard Ellis is marketing the property. [Crain’s]

 

Related Articles

arrow_forward_ios
RXR Realty head Scott Rechler and CBRE Tri-State CEO Mary Ann Tighe
Rechler, Tighe know which real estate players will go extinct
Rechler, Tighe know which real estate players will go extinct
(iStock)
Manhattan’s retail market ticks up toward rebound
Manhattan’s retail market ticks up toward rebound
Office subleases abound in North Dallas suburbs
Office subleases abound in North Dallas suburbs
Office subleases abound in North Dallas suburbs
CBRE to buy $4.9B global industrial portfolio
CBRE to buy $4.9B global industrial portfolio
CBRE to buy $4.9B global industrial portfolio
Demand and construction in life science real estate has reached record heights, led by Boston (right) and San Francisco. (iStock)
Boston, San Francisco lead surging life sciences market
Boston, San Francisco lead surging life sciences market
Former Newmark brokers Christopher Cowan, Shane Ozment, and Terrance Hunt (CoStar)
Ex-Newmark brokers appeal 1-year ban after judge upholds noncompete
Ex-Newmark brokers appeal 1-year ban after judge upholds noncompete
Altus CEO Mike Gordon and Reonomy's Richard Sarkis (Altus, Reonomy)
Software giant Altus acquires real estate data firm Reonomy for $200M
Software giant Altus acquires real estate data firm Reonomy for $200M
Retail availabilities decreased, but leasing increased in the third quarter (iStock, Wikimedia, LoopNet)
Manhattan retail market ticks up, indicating slow recovery
Manhattan retail market ticks up, indicating slow recovery
arrow_forward_ios

The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

Loading...